ArticleFrontiers in pharmacology2025

Persistent benefit of pharmacogenomic testing on initial remission and response rates in patients with major depressive disorder.

Daniel Hain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.